For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the ...
HealthDay News — For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8mg is efficacious and tolerable, according to a study ...
A phase 3 study compared two doses of ivarmacitinib with placebo in 330 adults. At week 24, about 35% in the 4 mg group and 40% in the 8 mg group had a SALT score of 20 or less vs. 9% in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback